Anzeige
Mehr »
Login
Montag, 29.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Fokus auf Nurexone: High-Level Biotech im Pennystock-Kleid!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
56 Leser
Artikel bewerten:
(0)

OFS to Present Paper on Optical Fibers with Polyimide Coatings for Medical Applications

AVON, Conn., Jan. 19, 2012 /PRNewswire/ --The Specialty Photonics Division of OFS Fitel, LLC (OFS SPD), a leading provider of optical fiber, cable, and assemblies for medical device manufacturers, announces that Dr. Andrei Stolov will present "Optical fibers with polyimide coatings for medical applications" at the upcoming BiOS Technology Conference. Dr. Stolov will present on Sunday, January 22nd at 12:10 PM, in room 206 (Mezzanine).

(Logo: http://photos.prnewswire.com/prnh/20120119/CL38819LOGO )

The focus of the work was to model extreme conditions that optical fibers may encounter in medical applications. Three commercially available fibers were examined. A battery of tests were completed analyzing how well each fiber withstood exposure to extreme heat and humidity, multiple autoclave cycles, extended water soak, and immersion in organic solvents. Key properties of polyimide-coated optical fibers, un-aged and exposed to various harsh environments, were investigated. Dr. Stolov commented that "The results of the work will certainly be of interest to engineers who are either evaluating or thinking of evaluating polyimide-coated fibers for their medical application."

OFS SPD will exhibit and showcase its line of optical fiber, cable, and assemblies for the medical market at the BiOS Tradeshow, January 21st-22nd.

About OFS

OFS is a world-leading designer, manufacturer and provider of optical fiber, optical fiber cable, FTTX, optical connectivity and specialty photonics products. Our manufacturing and research divisions work together to provide innovative products and solutions that traverse many different applications as they link people and machines worldwide. Between continents, between cities, around neighborhoods, and into homes and businesses of digital consumers we provide the right optical fiber, optical cable and components for efficient, cost-effective transmission.

OFS' corporate lineage dates back to 1876 and includes technology powerhouses such as AT&Tand Lucent Technologies (now Alcatel-Lucent. Today, OFS is owned by Furukawa Electric, a multi-billion dollar global leader in optical communications.

Headquartered in Norcross (near Atlanta) Georgia, U.S., OFS is a global provider with facilities in Avon, Connecticut; Carrollton, Georgia; Somerset, New Jersey; and Sturbridge, Massachusetts, as well as in Denmark, Germany and Russia. For more information, please visit www.ofsoptics.com.

About OFS, Specialty Photonics Division

OFS, Specialty Photonics Division, is an industry leader in optical fiber design or modification for highly specialized or customized applications. It supplies advanced optical fibers, including specialty multimode, specialty single-mode, rare-earth doped, polarization-maintaining and other nonstandard fibers. It also manufactures specialty cables and connectors, and other specialty products, such as high-power laser components. For more information about the Specialty Photonics Division, please visit: www.SpecialtyPhotonics.com.

SOURCE OFS, Specialty Photonics Division

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2012 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.